Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence".

Ørholt, Mathias; Eriksson, Frank; Herly, Mikkel; Vester-Glowinski, Peter

Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence".

Ørholt, Mathias; Eriksson, Frank; Herly, Mikkel; Vester-Glowinski, Peter.

Afiliación

Ørholt M; Department of Plastic Surgery and Burns Treatment, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. Electronic address: Mathias.oerholt.nielsen@regionh.dk.
Eriksson F; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Herly M; Department of Plastic Surgery and Burns Treatment, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Vester-Glowinski P; Department of Plastic Surgery and Burns Treatment, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

J Am Acad Dermatol ; 90(5): e175-e176, 2024 May.

Article en En | MEDLINE | ID: mdl-38185254

Asunto(s)

Histiocitoma Fibroso Maligno; Neoplasias Cutáneas; Humanos; Histiocitoma Fibroso Maligno/diagnóstico; Neoplasias Cutáneas/diagnóstico

Palabras clave

atypical fibroxanthoma; censoring; competing risks; metastasis; pleomorphic dermal sarcoma; recurrence; survival analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Histiocitoma Fibroso Maligno Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google